At CyberLiver, we are transforming hepatology and behavioral healthcare through cutting-edge Software as a Medical Device (SaMD), Artificial Intelligence as a Medical Device (AIaMD), and Digital Care solutions. Our mission is to bridge the gap between clinical care and digital innovation, ensuring early detection, intervention, and personalised treatment pathways for alcohol-related and liver diseases.
We are at a pivotal moment—with multiple NHS collaborations, RCT-backed evidence, UK market regulatory-approved platform and regulatory approval process for the EU market.
© 2012-2024 CyberLiver® Ltd All Rights Reserved